Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / B•• P••• C••••

B•• P••• C••••

Stage unknownStony Brook, NYOther
Facts
Year of incorporation
unknown
Revenue range (Form D)
$1,000,001 - $5,000,000sec.gov
Rounds on record
4
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
4 rounds
  1. May 28, 2026
    Form D equity offering · $2.5M (form d sold) · 1 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “B•• P••• C•••• filed Form D: $2,500,000 sold of $5,000,000, Other
  2. Sep 29, 2025
    Form D equity offering · $58.0M (form d sold) · 33 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Applied Dna Sciences Inc filed Form D: $58,000,000 sold of $58,000,000, Biotechnology
  3. Oct 30, 2024
    Form D equity offering · $0 (form d sold) · 8 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Applied Dna Sciences Inc filed Form D: no sales yet of $13,325,000, Biotechnology
  4. Feb 2, 2024
    Form D equity offering · $0 (form d sold) · 3 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Applied Dna Sciences Inc filed Form D: no sales yet of $6,874,466, Biotechnology
Investors on record
0 edges
No named investor yet.
People
12 officers, 8 directors
Timeline
4
  1. Jun 3, 2026
    B•• P••• C•••• filed Form D: $2,500,000 sold of $5,000,000, Other
  2. Oct 15, 2025
    Applied Dna Sciences Inc filed Form D: $58,000,000 sold of $58,000,000, Biotechnology
  3. Nov 6, 2024
    Applied Dna Sciences Inc filed Form D: no sales yet of $13,325,000, Biotechnology
  4. Feb 12, 2024
    Applied Dna Sciences Inc filed Form D: no sales yet of $6,874,466, Biotechnology
Evidence
56 observations
Every observation on this company